This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Trishul Shah, M.S.
Director, Business Development, North America at PolyPeptide Laboratories Inc.
Speaker

Profile

Trishul Shah is the Director of Business Development and Head of North American Sales for the PolyPeptide Group. He is involved in industry peer groups such as the TIDES Advisory committee, Boulder Peptide Symposium Scientific Board, a member of the PolyPeptide Group’s Executive Strategic Team in the US and member of the Global Management Group at PolyPeptide. Trishul joined the PolyPeptide Group as a peptide chemist in 2005 and in 2007 joined Allergan as a pre-formulation chemist. Upon returning to PolyPeptide in 2009, Trishul joined the Business Development group.

Agenda Sessions

  • Chairman’s Remarks: Macrocyclic Peptides and Peptide Discovery

    8:15am
  • Chairman’s Remarks: Oligonucleotide Preclinical and Clinical & Progress in the Development of Phosphorodiamidate Morpholino Oligonucleotides PMOs

    8:25am